December 2009
- December 18, 2009
-
RADIENT PHARMA Chinese Pharma Division Has Put In Place A Strategic Adivosry Agreement With Security Research Associates To Assist With The Sale or Financing of Jade Pharmaceutical
-
December 3, 2009
Radient Pharmaceutical Corporation's Q309 Earnings Conference Call 
-
December 1, 2009
RADIENT PHARMA Completes Registered Direct Offering For Approximately $1 Million
November 2009
-
November 30, 2009
RADIENT PHARMA Reschedules Third Quarter 2009 Earnings Conference Call To Thursday December 3, 2009
-
November 25, 2009
CEO, Douglas McLellan Interviewed on Steve Crowley's American Scene
-
November 24, 2009
RADIENT PHARMA Announces Third Quarter 2009 Financial Results
-
November 17, 2009
RADIENT PHARMA Files Extension For Third Quarter 2009 Financial Result
October 2009
-
October 15, 2009
RADIENT PHARMA Signs Research Collaboration Agreement With CeTeCancer
-
October 8, 2009
AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 ONKO-SURE™ Cancer Test
-
October 6, 2009
RADIENT PHARMA Enters Into Distribution Agreement to Launch Sales of Onko-Sure IVD Cancer Test in Israel
September 2009
-
September 29, 2009
RADIENT PHARMA Changes Corporate Name and Ticker Symbol Change
-
September 19, 2009
AMDL Inc. Announces Stockholder Approval of Name Change & Issuance of a New Trading Symbol on The NYSE Alternext US.
August 2009
-
August 21, 2009
AMDL Inc. Q209 Earnings Results Conference Call
-
August 20, 2009
AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.
-
August 19, 2009
AMDL Inc. Announces Second Quarter 2009 Financial Results
-
August 14, 2009
AMDL Inc. Files Notification of Late Filing For Form 10-Q
July 2009
-
July 8, 2009
AMDL Inc. Introduces New Brand Name For Its DR-70 (FDP) In Vitro Diagnostic Cancer Test
June 2009
-
June 17, 2009
AMDL Inc. CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
May 2009
April 2009
-
April 30, 2009
AMDL Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory For DR-70 (FDP) Cancer Test
-
April 29, 2009
Chinese Pharma Market Continues To Grow At A 5-7% Rate in 2009; AMDL Remains On Track To Meet FY09 Financial Targets
-
April 16, 2009
AMDL Inc. Conference Call
-
April 15, 2009
AMDL Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Targets
March 2009
-
March 11, 2009
AMDL Inc. Enters Into Collaboration Agreement To Advance Development of Its AMDL DR-70 (FDP) Cancer Test
-
March 6, 2009
Chinese Pharma Market Continues To Grow At A 5-7% Rate in 2009; AMDL Remains On Track To Meet FY09 Financial Targets
February 2009
-
February 4, 2009
AMDL Inc's. Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009
January 2009
-
January 30, 2009
AMDL Inc. Announces Final Closing of Private Placement of Senior Notes
-
January 29, 2009
AMDL Inc. First To Implement US & China Based, GAAP Certified Accounting Technology To Capitalize On Lucrative China Healthcare Market
-
January 27, 2009
AMDL Inc. Announces 2009 Financial Guidance and First Quarter Objectives
-
AMDL Inc. Chairman & CEO Announces Expert Opinion On China's Economic Forecast
-
AMDL 2009 Economic Forecast For China
-
January 8, 2009
AMDL Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
-
January 6, 2009
Rudd Report Gives AMDL Inc. Strong Buy Recommendation In Year-End Financial Research Report
|
